• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

AdhereHealth Launches COVID-19 Adherence Solution for High Risk Populations

by Fred Pennic 05/06/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

AdhereHealth Launches COVID-19 Adherence Solution for High Risk Populations

What You Should Know:

– AdhereHealth launches COVID-19 Adherence Solution to help protect high-risk populations and reduce unnecessary hospitalizations during COVID-19 pandemic.

– The new solution combines predictive analytics, proactive outreach and home-delivered pharmacy services to help high-risk patients overcome SDOH challenges and continue taking their prescribed medications throughout the COVID-19 crisis. 

Nashville, TN-based AdhereHealth today announced the immediate availability of its new COVID-19 Adherence Solution, an innovative program that combines comprehensive predictive analytics and tech-enabled consumer outreach with home-delivered pharmacy services to support the Coronavirus crisis response.

Growing Importance of Leveraging Social Determinants of Health

COVID-19 has exacerbated existing social determinant of health (SDOH) issues and medication adherence challenges for underserved populations. Statistics show almost 90% of those who are hospitalized with the virus have underlying conditions, and a majority are over the age of 50.

COVID-19 Adherence Solution Features

AdhereHealth’s COVID-19 Adherence Solution program helps improve health outcomes for at-risk populations by enabling health plans and employers with:

·   Comprehensive predictive analytics to identify populations at higher risk of medication non-adherence

·   Support from a team of nationwide employed licensed clinicians who provide direct omnichannel consumer and provider engagement to discuss health status and coordinate care

·    Data-driven outreach designed to resolve SDOH issues in the context of COVID-19 using available health plan benefits and community resources

·       Private-couriered medication delivery services catering to vulnerable populations

“In normal times, a staggering 50% of patients who are managing chronic conditions don’t take their medications as directed. Factor in continued lockdowns, social distancing and economic hardships  – and it’s easy to see how non-adherence is likely to get worse. Engaging with consumers proactively gives us a chance to get them support before they wind up in a hospital bed.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Coronavirus (COVID-19), medication, Medication Adherence, Medication Non-Adherence, Pharmacy, Predictive Analytics, risk, Social Determinants of Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Oracle Lays Off 539 Kansas City Employees as Focus Shifts to AI Data Centers

Oracle Lays Off 539 Kansas City Employees as Focus Shifts to AI Data Centers

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

HHS Reverses 2024 Tech Reorganization: Why HHS Just Stripped AI and Cyber Operations Out of the ONC

How Small Medical Practices Can Build HIPAA-Aligned DevSecOps Without Enterprise Budgets

How Small Medical Practices Can Build HIPAA-Aligned DevSecOps Without Enterprise Budgets

Insilico Medicine and Eli Lilly Form $2.75B AI Drug Discovery Collaboration

Insilico Medicine and Eli Lilly Form $2.75B AI Drug Discovery Collaboration

Microsoft Copilot Health, Integrates Apple Health, Oura, and 50,000 EHRs in New AI Push

Microsoft Launches Copilot Health, Integrates Apple Health, Oura, and 50,000 EHRs in New AI Push

Health Recovery Solutions (HRS) Acquires Rimidi for Chronic Care Management and RPM Integration

Health Recovery Solutions (HRS) Acquires Rimidi for Chronic Care Management and RPM Integration

RadNet Subsidiary DeepHealth Acquires French Radiology AI Leader Gleamer

RadNet’s $269M AI Play: DeepHealth Acquires French AI Gleamer

Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients

Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients

KLAS Digital Pathology 2026 Report: Top IMS, Scanner, and AI Vendors Evaluated

KLAS Digital Pathology 2026 Report: Top IMS, Scanner, and AI Vendors Evaluated

The "Platform" Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

The “Platform” Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |